MEMSCAP and OrthoMEMS team up to develop biomedical sensor
5 June 2009
MEMSCAP (Euronext:MEMS), a provider of micro-electro-mechanical systems (MEMS), and OrthoMEMS, a medical device company focused on biomedical applications of patented MEMS and wireless technology from Cleveland Clinic, have entered a multi-year strategic partnership and development agreement to manufacture a MEMS sensor for the assessment and treatment of mechanical low back pain.
For Grenoble-based MEMSCAP, the partnership is a key component of its plan to expand its manufacturing presence in the US medical device sector with revolutionary products. For OrthoMEMS, the partnership aggressively advances the development of its breakthrough spine product all the way to market with a leading MEMS supplier to medical device companies.
The combined experience and technologies of MEMSCAP and OrthoMEMS enables the development and commercialization of the OrthoChip, a miniature, battery-less, wireless pressure sensor that will provide an objective measurement of spinal disc pressures.
The OrthoChip is designed to detect clear-cut pressure differences between normal and mechanically unstable spinal segments and to communicate the results telemetrically to a read-out unit. This new capability is expected to significantly alter indications for surgery and non-surgical treatments. No other technology, existing or emerging, provides this advantage.
As the leading cause of adult disability, spine conditions are widespread. An estimated 26 million people per year in the United States alone report back pain severe enough to seek relief from a physician. $90 Billion, or 1% of the US gross domestic product, was spent on back pain in 1998.
“OrthoMEMS is an attractive partner because of its strong business and scientific team and the significant commercial potential of its spine application. This partnership is in-line with our strategic commitment to be the lead manufacturer of MEMS in medicine,” stated Steve Wilcenski, General Manager of the MEMSCAP Custom Products Business Unit.
“MEMSCAP has a clear track record of success in developing and manufacturing high-value added MEMS sensors for medical use. This strategic partnership adds real value across our full product cycle – from the design-in phase to the market launch of our ground-breaking product that changes the way clinicians interact with the human body,” said Douglas Lee, Chairman and CEO of OrthoMEMS.
Bookmark this page